文献速递关节外科

无菌性翻修全膝关节置换术中未预期的培养阳性:患病率、管理与无感染生存率

Unsuspected Positive Intraoperative Cultures in Aseptic Revision Knee Arthroplasty: Prevalence, Management, and Infection-Free Survivorship.
PubMed 文献 · J Arthroplasty · 2024-06-08

单中心回顾性研究纳入2013年1月至2023年10月691例无菌性翻修全膝关节置换,比较术中培养结果分4组的无感染生存率。5年无感染生存率:无菌组96% vs 1次阳性组89%(P=0.39),无菌组96% vs 同种菌≥2次阳性组58%(P<0.001),无菌组96% vs 不同菌≥2次阳性组100%(P<0.72)。同种菌≥2次阳性与再翻修风险升高相关(HR=11.0)。

要点

  • 无菌性翻修TKA中1次培养阳性占7.1%,同种菌≥2次阳性占1.4%,不同菌≥2次阳性占0.2%。
  • 同种菌≥2次阳性组5年无感染生存率58%,显著低于无菌组96%(P<0.001)。
  • 1次阳性或不同菌≥2次阳性组5年无感染生存率与无菌组无显著差异。

核心结论

  • 1次培养阳性或不同菌≥2次阳性的患者5年无感染生存率与无菌培养患者相似。
  • 同种菌≥2次阳性的患者5年无感染生存率显著更差。
  • 总体而言,翻修TKA时1次阳性或同种菌≥2次阳性可能提示再翻修风险较高。
  • 需要更多研究来确定可采取哪些干预措施来降低该风险。

研究设计与样本

  • 单中心三级医院机构数据库回顾性分析2013年1月至2023年10月无菌性翻修全膝关节置换术。
  • 排除符合Musculoskeletal Infection Society(MSIS)假体周围感染(PJI)标准、使用抗生素间隔物或随访不足1年的患者。
  • 按术中培养分为4组:无菌培养、1次阳性、≥2次阳性不同菌、≥2次阳性同种菌。
  • 共纳入691例翻修TKA,平均随访4.2年;采用Kaplan-Meier生存分析和Cox比例风险回归。

主要发现

  • 49例(7.1%)为1次阳性新病原体,10例(1.4%)为同种菌≥2次阳性,2例(0.2%)为不同菌≥2次阳性。
  • 术后抗生素使用:114例(16.5%)总体;1次阳性组13例(26.5%),同种菌≥2次阳性组6例(60.0%),不同菌≥2次阳性组0例(0.0%)。
  • 5年无感染生存率:无菌组96% vs 1次阳性组89%(P=0.39),无显著差异。
  • 5年无感染生存率:无菌组96% vs 不同菌≥2次阳性组100%(P<0.72),无显著差异。
  • 5年无感染生存率:无菌组96% vs 同种菌≥2次阳性组58%(P<0.001),同种菌≥2次阳性组显著更差。

关键数值与推荐

  • 校正混杂因素后,ASA分级≥3与再翻修风险升高相关(HR=3.1;P=0.007)。
  • 校正混杂因素后,同种菌≥2次阳性与再翻修风险升高相关(HR=11.0;P<0.001)。
  • 校正混杂因素后,1次阳性与再翻修风险升高相关(HR=4.2;P=0.018)。
  • 校正混杂因素后,铰链式假体翻修TKA与再翻修风险升高相关(HR=4.1;P=0.008)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to evaluate the management and outcomes of aseptic revision total knee arthroplasty (arTKA) with unsuspected positive cultures (UPCs) compared to those with sterile cultures. METHODS: The institutional database at a single tertiary center was retrospectively reviewed for arTKA from January 2013 to October 2023. Patients who met Musculoskeletal Infection Society criteria for periprosthetic joint infection (PJI) based on available preoperative infectious workup, received antibiotic spacers, or did not have at least 1 year of follow-up were excluded. Patients were stratified based on intraoperative cultures into 4 cohorts: sterile cultures, 1 UPC, ≥ 2 UPCs with different organisms, and ≥ 2 UPCs with the same organism. Univariable analyses were used to compare these groups. Kaplan-Meier survivorship analysis assessed infection-free survival at 5 years, and Cox proportional hazards regressions were used to evaluate factors that influence infection-free survival. A total of 691 arTKAs at a mean follow-up of 4.2 years were included in the study. Of these, 49 (7.1%) had 1 UPC with a new organism, 10 (1.4%) had ≥2 UPCs of the same organism, and 2 (0.2%) had ≥2 UPCs with different organisms. RESULTS: Postoperative antibiotics were prescribed to 114 (16.5%) patients-13 (26.5%) with 1 UPC, 6 (60.0%) with ≥2 UPCs of the same organism, and 0 (0.0%) of patients who had ≥2 UPCs of different organisms. There were no differences in infection-free survival at 5 years between patients who had sterile cultures and 1 UPC (96 versus 89%; P = .39) nor between sterile cultures and ≥2 UPCs of different organisms (96 versus 100%; P < .72). However, patients who had ≥2 UPCs of the same organism had significantly worse infection-free survival at 5 years compared to patients who had sterile cultures (58 versus 96%; P < .001). Cox proportional hazards regression suggested that when adjusting for covariates, an American Society of Anesthesiologists classification of ≥3 (hazard ratio [HR] = 3.1; P = .007), ≥2 UPCs of the same organism (HR = 11.0; P < .001), 1 UPC (HR = 4.2; P = .018), and arTKA with hinge constructs (HR = 4.1; P = .008) were associated with increased risk of rerevision for PJI. CONCLUSIONS: Patients who had 1 UPC or ≥2 UPCs with different organisms had similar infection-free survival at 5 years as patients who had sterile cultures. However, patients who had ≥2 UPCs of the same organism had significantly worse infection-free survival at 5 years. Overall, 1 UPC or ≥2 UPCs of the same organism at the time of arTKA may suggest the patient is at higher risk of rerevision for PJI. More studies are needed to determine what interventions can be implemented to mitigate this risk.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Wu CJ, Leal J, Seyler TM, et al. Unsuspected Positive Intraoperative Cultures in Aseptic Revision Knee Arthroplasty: Prevalence, Management, and Infection-Free Survivorship. J Arthroplasty. 2024. PMID: 38857712. doi:10.1016/j.arth.2024.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。